Home Logon FTA Investment Managers Blog Subscribe About Us Contact Us

Search by Ticker, Keyword or CUSIP       
Blog Home
Bob Carey
Chief Market Strategist
X •  LinkedIn

  Biotechnology And Internet Stocks Appear To Have Passed The “Bubble Test”
Posted Under: Broader Stock Market
Supporting Image for Blog Post


View from the Observation Deck 

  1. Since 2000, equity investors have endured the fallout from the popping of two investment-related bubbles: the Internet Revolution (dot.com bomb) and housing (subprime mortgages/securitization).
  2. It is only natural that investors would want to keep an eye out for any future bubbles in order to protect their capital. Two sectors of the market were called out as potential bubble candidates in the first half of 2014. 
  3. Biotechnology and Internet-related stocks, particularly social media companies, were the ones targeted. Even Janet Yellen, Chair of the Federal Reserve, suggested there could be some froth in their valuation levels. 
  4. From 3/9/09-8/13/14, the NYSE Arca Biotechnology Index and Dow Jones Internet Composite Index posted cumulative total returns of 431.0% and 387.2%, respectively, compared to the 223.0% gain for the S&P 500.
  5. Biotechnology and Internet-related stocks experienced sell-offs of better than 19% in the first half of 2014, as measured by the indices in the chart. Biotech stocks were also scrutinized about the issue of high price tags on some new drugs.
  6. As indicated in the chart, the broader market (S&P 500) did not experience a deep correction, but did sustain some single-digit pullbacks. To date, investors have bought those dips.
  7. Investors have returned to biotech and Internet-related stocks. The NYSE Arca Biotechnology Index has recovered nearly all of its losses, while the Dow Jones Internet Composite index has recovered over half of its losses.
  8. It looks as though the bubble talk for these two sectors may have been overstated. We believe, however, that such scrutiny is a healthy thing. The lesson learned from the previous bubbles is to make sure the facts match the hype.

This chart is for illustrative purposes only and not indicative of any actual investment. The illustration excludes the effects of taxes and brokerage commissions and other expenses incurred when investing. Investors cannot invest directly in an index. There can be no assurance that any of the projections cited will occur. The S&P 500 Index is a capitalization-weighted index comprised of 500 stocks used to measure large-cap U.S. stock market performance. The NYSE Arca Biotechnology Index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry. The Dow Jones Internet Composite Index is a modified capitalization-weighted index that tracks companies involved in Internet-related activities.

To Download a PDF of this post, please click here.

Posted on Thursday, August 14, 2014 @ 2:15 PM • Post Link Print this post Printer Friendly

These posts were prepared by First Trust Advisors L.P., and reflect the current opinion of the authors. They are based upon sources and data believed to be accurate and reliable. Opinions and forward looking statements expressed are subject to change without notice. This information does not constitute a solicitation or an offer to buy or sell any security.
Search Posts
Market Commentary and Analysis
Market Commentary Video
Monthly Talking Points
Quarterly Newsletter
Market Observations
Subscribe To Receive Email

What Investors Did During the Correction
A Snapshot Of Major Emerging Market Stock Indices
Interview with Bob DeRochie
Snapshot Of U.S. Equity Styles/Market Caps
Master Limited Partnerships (MLPs) Have Shined Since The Start Of The New Millennium
It’s Time To Look Ahead To 2015
2 Natural Resource Sectors Have Kept Pace With 2 Defensive Sectors Since 3/24/00
The Energy Trade Is Still Working For Investors
It Looks Like Gold & Silver Miners May Finally Be Joining The Bull
Companies Are Earning Their Keep
Skip Navigation Links.
Search by Topic
Skip Navigation Links.

The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
Follow First Trust:  
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2024 All rights reserved.